EMBL Enterprise Management Technology Transfer

EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) serves as the exclusive technology and knowledge transfer partner for the European Molecular Biology Laboratory (EMBL). It identifies, protects, and commercializes intellectual property and know-how from EMBL scientists. EMBLEM manages inventions and patents, translating discoveries into applications via spin-off companies, licensing, and industry collaborations.

Established in May 1999, EMBLEM arose from EMBL’s 1998 decision to separate commercial activities, preserving its intergovernmental status. This allowed independent commercial pursuit. Managing Director Gábor Lamm has guided the organization since inception, focusing on bridging academic research with industrial innovation.

EMBLEM partners with industry for licenses, investors for new ventures, and EMBL scientists for commercialization. Its vision advances human health by accelerating market deployment of novel diagnostics, therapies, and medical devices from research. It ensures broad access and effective utilization of these technologies.